Mestranol

Hazard statements (CLP)

H315, H319, H351

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Carcinogenicity, (Category 2) H351: Suspected of causing cancer.

Signal word

Warning Warning

Hazard statements

H315 Causes skin irritation. H319 Causes serious eye irritation. H351 Suspected of causing cancer. H351 Suspected of causing cancer.

Precautionary statements

P201 Obtain special instructions before use. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

none Reduced Labeling (<= 125 ml) none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.